Younghwa J. Na
Pocheon-si, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications
Discovery of a Small-Molecule Inhibitor Targeting the ELF3-HSP27 Interaction to Suppress Breast Cancer Progression.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 16, 2026
KN21, a direct AMPK activator, alleviates hepatic steatosis and fibrosis by modulating long-chain TAG and pyrimidine metabolism in a MASH mouse model.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: September 08, 2025
Modulation of AMPK/NLRP3 Signaling Mitigates Radiation-Induced Lung Inflammation by a Synthetic Lipoxin A4 Analogue.
Journal: International journal of molecular sciences
Published: July 07, 2025
Pharmacological Activation of AMP-activated Protein Kinase Ameliorates Liver Fibrosis in a Metabolic Dysfunction-Associated Steatohepatitis Mouse Model.
Journal: International journal of biological sciences
Published: December 13, 2024
Computer-aided discovery of novel AMPK activators through virtual screening and SAR-driven synthesis.
Journal: European journal of medicinal chemistry
Published: November 13, 2024
Targeting the HER2-ELF3-KRAS axis: a novel therapeutic strategy for KRASG13D colorectal cancer.
Journal: Molecular cancer
Published: October 19, 2024
The Nα-acetyl-L-lysine/Loxl2/H2O2 promotes intestinal tumor growth in Drosophila and cell proliferation in human colorectal cancer.
Journal: Cell reports
Published: August 11, 2024
Calpain 2 Isoform-Specific Cleavage of Filamin A Enhances HIF1α Nuclear Translocation, Promoting Metastasis in Triple-Negative Breast Cancer.
Journal: MedComm
Published: July 30, 2024
Radiosensitizing effect of a novel CTSS inhibitor by enhancing BRCA1 protein stability in triple-negative breast cancer cells.
Journal: Cancer science
Published: October 18, 2023
Drug like HSP27 cross linkers with chromenone structure ameliorates pulmonary fibrosis.
Journal: Frontiers in pharmacology
Published: April 10, 2023
Synthesis and evaluation of 7-(3-aminopropyloxy)-substituted flavone analogue as a topoisomerase IIα catalytic inhibitor and its sensitizing effect to enzalutamide in castration-resistant prostate cancer cells.
Journal: European journal of medicinal chemistry
Published: November 21, 2022
Last Updated: 09/26/2026